These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32894884)

  • 1. Low vancomycin trough concentration in neonates and young infants.
    Maruyama H; Tanzawa A; Funaki T; Ito Y; Isayama T
    Pediatr Int; 2021 May; 63(5):556-560. PubMed ID: 32894884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Index for the appropriate vancomycin dosing in premature neonates and infants.
    Endo A; Nemoto A; Hanawa K; Ishikawa T; Koshiishi M; Maebayashi Y; Hasebe Y; Naito A; Kobayashi Y; Isobe K; Kawano Y; Hanawa T
    Pediatr Int; 2022 Jan; 64(1):e14905. PubMed ID: 34197665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.
    Yu YX; Lu J; Lu HD; Li L; Li JJ; Shi L; Duan LF; Zhuang ZW; Xue SD; Shen Y; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(e1):e6-e14. PubMed ID: 33414258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
    Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
    Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation.
    Weng XH; Zhu CQ; Duan LF; Li L; Yang ZM; Wang SN; Cai Y; Li JJ; Yu YX; Feng ZT; Tang L
    Eur J Hosp Pharm; 2022 Mar; 29(2):101-108. PubMed ID: 33472817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2011 Apr; 131(4):563-70. PubMed ID: 21467796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.
    Shigemura K; Osawa K; Yamamichi F; Tanaka K; Tokimatsu I; Arakawa S; Fujisawa M
    Int Urol Nephrol; 2015 Jun; 47(6):887-91. PubMed ID: 25899764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
    Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.
    Tseng SH; Lim CP; Chen Q; Tang CC; Kong ST; Ho PC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Komatsu T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Ther Drug Monit; 2018 Feb; 40(1):109-114. PubMed ID: 29095798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adults.
    Maki N; Ohkuchi A; Tashiro Y; Kim MR; Le M; Sakamoto T; Matsubara S; Hakamata Y
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2537-43. PubMed ID: 22391760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
    Moriyama H; Tsutsuura M; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
    J Infect Chemother; 2021 May; 27(5):781-785. PubMed ID: 33563525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Yoo RN; Kim SH; Lee J
    J Korean Med Sci; 2017 Jan; 32(1):22-28. PubMed ID: 27914127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients.
    Chung J; Oh JM; Cho EM; Jang HJ; Hong SB; Lim CM; Koh YS
    Anaesth Intensive Care; 2011 Nov; 39(6):1030-7. PubMed ID: 22165354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases.
    Matsunaga N; Hisata K; Shimizu T
    Medicine (Baltimore); 2015 Jun; 94(22):e922. PubMed ID: 26039127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.
    Komoto A; Maiguma T; Teshima D; Sugiyama T; Haruki Y
    PLoS One; 2018; 13(9):e0203453. PubMed ID: 30188918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
    J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.